GlassScriptPhysician profile
George R Rix
NPI 1629485735
$1,817.11
in general payments reported to CMS, 2019-2025
15 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $250 · 2021: $174 · 2022: $126 · 2023: $346 · 2024: $356 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $418.36 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $325.07 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Abbvie INC. | $296.54 | 2023-2025 | Durysta, Vuity, Lumigan |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2019 | |
| Rxsight INC | $116.03 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| New World Medical,INC. | $98.62 | 2023 | |
| Biotissue Holdings INC. | $79.12 | 2025 | |
| Alimera Sciences, INC. | $75.78 | 2019 | |
| Alcon Vision LLC | $73.18 | 2019-2025 | Tryptyr, Eysuvis |
| Sun Pharmaceutical Industries INC. | $62.90 | 2020-2025 | |
| Glaukos Corporation | $53.34 | 2019 | |
| Allergan, INC. | $30.54 | 2021 | |
| Optos, INC. | $22.66 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $21.34 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $18.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Rix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.